CLAIRE RALEY: Open Payments
NPI 1336697457 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 20 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $291 · 2025 $597
Food & beverage: $544Education: $53
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $257 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Boston Scientific Corporation | 3 | $72 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Optinose US, Inc. | 2 | $46 |
| GENZYME CORPORATION | 1 | $29 |
| Amgen Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $20 |
Products named: NUCALA, DUPIXENT, WaveWriter Alpha Prime 16, Xhance, UBRELVY.
Industry payments across AL — which companies pay providers there.
